hepatitis B core antigen; HBeAg, hepatitis B early antigen; PCNA LI, proliferating cell nuclear antigen labeling index; S-R, sustained-response; S-NR, sustained-non-response. Combination treatment ...

Researchers update clinical practice guidelines for how to prevent and monitor hepatitis B virus reactivation.

The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to brelovitug (BJT-778) for the treatment of chronic hepatitis delta (CHD).

In a new clinical practice guideline, the AGA provided evidence-based recommendations for either antiviral prophylaxis or continued surveillance to manage hepatitis B virus reactivation in patients ...

The (AGA) has unveiled an updated clinical practice guideline in Gastroenterology addressing the prevention and management of hepatitis B virus reactivation (HBVr) in patients on immunosuppressive ...

Chronic Hepatitis B virus (HBV) is associated with elevated levels of hepatitis B surface antigen (HBsAg). Here the authors characterize the T cell responses to three variants of an HBsAg ...

Discover a clinical trial that was conducted to evaluate the efficacy and safety of autologous HBV vaccine-pulsed dendritic cells and their induced T cells.

These additions include single-gene sequencing for seven different cancers, hepatitis B core-related antigen (HBcrAg), and surface antigen quantitative tests, and the Ozaki procedure for aortic ...

View and download the form for terms and conditions for use of core. T cells play essential effectors and ... Human Papilloma Virus, Hepatitis B, Hepatitis C, Influenza, Measles and viruses for Rhesus ...

Hepatocyte cell cycle may influence hepatitis B virus (HBV) replication and hepatitis B core antigen (HBcAg) expression, which is a major target for antiviral immune response. The aim of the ...